Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00586963 · ClinicalTrials.gov registry record
Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 65
- Enrollment target
NCT00586963: Completed study, sponsored by Mayo Clinic.
NCT00586963 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00586963 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
This study is being done to for two reasons: * To learn about the effects (good and bad) esomeprazole (an FDA approved drug for reflux esophagitis) has on your esophagus when taken correctly. * To learn about the quality of life changes (good and bad) you may experience with this medication.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00586963
The ClinicalTrials.gov registry entry for NCT00586963 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00586963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00586963 about?
NCT00586963 is a clinical study titled "Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis". This study is being done to for two reasons: * To learn about the effects (good and bad) esomeprazole (an FDA approved drug for reflux esophagitis) has on your esophagus when taken correctly. * To learn about the quality of life changes (good and bad) you may experience with this medication.
What is the current status of trial NCT00586963?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2008-01. Estimated completion is 2008-12.
Who is sponsoring clinical trial NCT00586963?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.